Correction to: Acta Pharmacologica Sinica https://doi.org/10.1038/s41401-020-0443-1, published online 23 July 2020
A Western blot image in Fig. 6a (NRF2 protein expression in HCC827ER cells) was inadvertently misplaced in the process of assembling figures. The correct version is shown. The corrigendum does not affect the interpretation of data and conclusions. The authors would like to apologize for any inconvenience this may have caused.
Fig. 6 NRF2-induced resistance to EGFR-TKIs depends on SOD2 and GPX4. a Western blot analysis of NRF2, GPX4, and SOD2 protein expression.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Ma, Cs., Lv, Qm., Zhang, Kr. et al. Author Correction: NRF2-GPX4/SOD2 axis imparts resistance to EGFR-tyrosine kinase inhibitors in non-small-cell lung cancer cells. Acta Pharmacol Sin 44, 2346 (2023). https://doi.org/10.1038/s41401-023-01131-5
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41401-023-01131-5
